Publications

Ibrutinib Versus Temsirolimus in Patients with Relapsed or Refractory Mantle-Cell Lymphoma: an International, Randomised, Open-Label, Phase Study

AuthID
P-00K-7CK

Author(s)

Dreyling, M

Jurczak, W

Jerkeman, M

Silva, RS

Rusconi, C

Trneny, M

Offner, F

Caballero, D

Joao, C

Witzens Harig, M

[+3]·

Bothos, J

Goldberg, JD

Enny, C

Traina, S

Balasubramanian, S

Bandyopadhyay, N

Sun, S

Vermeulen, J

Rizo, A

Rule, S

View all authors

Document Type

Article

Year published

2016

Published

in LANCET, ISSN: 0140-6736

Volume: 387, Issue: 10020, Pages: 770-778 (9)

Indexing

Wos^®

Scopus^®

Crossref^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/s0140-6736(15)00667-4

Scopus: 2-s2.0-84959074796

Wos: WOS:000370418000036

Source Identifiers

ISSN: 0140-6736

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

All authors

Name Order	Name	Name Order	Name	Name Order	Name
1	Dreyling, M;	2	Jurczak, W;	3	Jerkeman, M;
4	Silva, RS;	5	Rusconi, C;	6	Trneny, M;
7	Offner, F;	8	Caballero, D;	9	Joao, C;
10	Witzens Harig, M;	11	Hess, G;	12	Bence Bruckler, I;
13	Cho, SG;	14	Bothos, J;	15	Goldberg, JD;
16	Enny, C;	17	Traina, S;	18	Balasubramanian, S;
19	Bandyopadhyay, N;	20	Sun, S;	21	Vermeulen, J;
22	Rizo, A;	23	Rule, S;

Ibrutinib Versus Temsirolimus in Patients with Relapsed or Refractory Mantle-Cell Lymphoma: an International, Randomised, Open-Label, Phase Study

Useful Links

Get Help

Federated Authentication (Click on the image)

Ibrutinib Versus Temsirolimus in Patients with Relapsed or Refractory Mantle-Cell Lymphoma: an International, Randomised, Open-Label, Phase Study

Useful Links

Get Help